Liver Fibrosis and Cirrhosis
Liver fibrosis and cirrhosis are both conditions that affect the liver, but they represent different stages of liver disease.
Liver Fibrosis: This condition involves the accumulation of excessive scar tissue (fibrosis) in the liver. It typically occurs in response to chronic liver injury, such as from hepatitis C infection, chronic alcohol consumption, non-alcoholic fatty liver disease (NAFLD), or other causes. Fibrosis is the body's way of trying to repair liver damage. In the early stages, liver fibrosis may not cause noticeable symptoms, but as it progresses, it can lead to more severe liver dysfunction.
Cirrhosis: Cirrhosis is an advanced stage of liver fibrosis characterized by widespread scarring (fibrosis) and the distortion of the liver's normal structure. In cirrhosis, healthy liver tissue is replaced by scar tissue, which impairs the liver's ability to function properly. Cirrhosis is often irreversible and can lead to serious complications, including liver failure, portal hypertension (high blood pressure in the liver's portal vein system), ascites (accumulation of fluid in the abdomen), hepatic encephalopathy (brain dysfunction due to liver failure), and an increased risk of liver cancer.
Both liver fibrosis and cirrhosis can result from various causes, including chronic viral hepatitis (such as hepatitis B and C), excessive alcohol consumption, non-alcoholic fatty liver disease (NAFLD), autoimmune liver diseases, genetic disorders, and certain medications or toxins. Early detection and management of the underlying causes are crucial in preventing or slowing the progression of liver fibrosis to cirrhosis and reducing the risk of complications.
Related Conference of Liver Fibrosis and Cirrhosis
7th International Conference on Gastroenterology and Liver Diseases
24th International Conference on Gastroenterology and Digestive Disorders
26th International Conference on Gastroenterology and Hepatology
20th World Congress on Gastroenterology -Therapeutics & Hepatology
17th International Conference on Liver Diseases & Hepatology
Liver Fibrosis and Cirrhosis Conference Speakers
Recommended Sessions
- Advanced Therapy and Treatments Techniques
- Artificial Intelligence and Digital Health in Gastroenterology and Hepatology
- Clinical Research in Gastroenterology and Liver Diseases
- Gall Bladder Disorders & Diseases - Treatment
- Gastro Emergency Care and Nursing
- Gastro Screening and Diagnosis
- Gastroenterology
- Gastroenterology & Pregnancy
- Gastrointestinal Diseases and Disorders
- Gastrointestinal Endoscopy
- Gastrointestinal Inflammation and Treatment
- Gastrointestinal Oncology
- Gastrointestinal Surgery
- Gut Microbiome - Digestive Health
- Hepatitis
- Liver Cancer
- Liver diseases
- Liver Fibrosis and Cirrhosis
- Liver Regeneration and Stem Cell Therapy
- Liver Transplantation and Liver Biopsy
- Neuro Gastroenterology
- Pancreatic Disorders & Diseases- Treatment
- Prebiotics and Probiotics
- Upper GI Tract, small & Large Intestine
Related Journals
Are you interested in
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Gastrointestinal Therapeutics - Gastroenterology – 2025 (France)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Liver Transplantation - Gastroenterology-2025 (UAE)
- Advances in Pancreatic Disease Management - Gastroenterology-2025 (UAE)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Artificial Intelligence in Gastroenterology - Gastroenterology-2025 (UAE)
- Bariatric Endoscopy & Obesity Management - Gastroenterology-2025 (UAE)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease and Gluten-Related Disorders - Gastroenterology – 2025 (France)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Cirrhosis & Portal Hypertension Management - Gastroenterology-2025 (UAE)
- Colorectal Cancer: Prevention, Screening, and Treatment - Gastroenterology – 2025 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Early Detection of Gastrointestinal Cancers - Gastroenterology-2025 (UAE)
- Emerging Biomarkers in Gastroenterology - Gastroenterology-2025 (UAE)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Emerging Therapies for Inflammatory Bowel Disease - Gastroenterology-2025 (UAE)
- Endoscopic Innovations and Techniques - Gastroenterology – 2025 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- FMT & Microbiota-Based Therapies - Gastroenterology-2025 (UAE)
- Functional GI Disorders & Motility Diseases - Gastroenterology-2025 (UAE)
- Functional GI Disorders: IBS and Beyond - Gastroenterology – 2025 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Antimicrobial Resistance - Gastroenterology – 2025 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology: From Screening to Targeted Therapies - Gastroenterology – 2025 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- GI Bleeding & Emergency Endoscopy - Gastroenterology-2025 (UAE)
- GI Oncology: Colorectal and Pancreatic Cancers - Gastroenterology – 2025 (France)
- Gut Microbiome in GI Diseases - Gastroenterology-2025 (UAE)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Immunotherapy in GI Cancers - Gastroenterology-2025 (UAE)
- Inflammatory Bowel Disease (IBD): Crohn’s and Ulcerative Colitis - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease (IBD): Insights and Advancements - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Innovations in Endoscopy - Gastroenterology-2025 (UAE)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Cirrhosis and Complications - Gastroenterology – 2025 (France)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastroenterology – 2025 (France)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Microbiome and Gut Health - Gastroenterology – 2025 (France)
- NAFLD & NASH Management - Gastroenterology-2025 (UAE)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH - Gastroenterology – 2025 (France)
- Nutrition & Liver Health - Gastroenterology-2025 (UAE)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology Breakthroughs - Gastroenterology-2025 (UAE)
- Pediatric Gastroenterology: Challenges and Innovations - Gastroenterology – 2025 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer Disease and H. pylori Infection - Gastroenterology – 2025 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Post-COVID GI Complications - Gastroenterology-2025 (UAE)
- Precision Medicine in Hepatology - Gastroenterology-2025 (UAE)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis Treatment Innovations - Gastroenterology-2025 (UAE)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)